Cleared Traditional

K962199 - QUANTEX C3

K962199 is an FDA 510(k) clearance for QUANTEX C3, manufactured by Instrumentation Laboratory CO. The device is a Class 2 Immunology device with product code CZW cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K962199 · Instrumentation Laboratory CO · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1996
Decision
110d
Days
Class 2
Risk

K962199 is an FDA 510(k) clearance for the QUANTEX C3. Classified as Complement C3, Antigen, Antiserum, Control (product code CZW), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Lexington, US). The FDA issued a Cleared decision on September 25, 1996 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5240 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Instrumentation Laboratory CO devices

FDA 510(k) Submission Details - K962199

510(k) Number K962199 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 1996
Decision Date September 25, 1996
Days to Decision 110 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 105d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CZW Device Classification - Class 2, Special Controls

Product Code CZW Complement C3, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5240
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CZW Complement C3, Antigen, Antiserum, Control

All 35
Devices cleared under the same product code (CZW) and FDA review panel - the closest regulatory comparables to K962199.
N-ASSAY TIA MULTI V-NL
K964298 · Crestat Diagnostics, Inc. · Jul 1997
IMMAGE IMMUNOCHEMISTRY SYSTEM COMPLEMENTC3 (C3) AND COMPLEMENTC4 (C4) REAGENT
K964842 · Beckman Instruments, Inc. · Jun 1997
OLYMPUS C3 IMMUNOTURBIDIMETRIC REGENT
K962409 · Olympus America, Inc. · Oct 1996
N PROTEIN STANDARS SY
K955857 · Behring Diagnostics, Inc. · Feb 1996
N PROTEIN STANDARD SY
K952594 · Behring Diagnostics, Inc. · Jul 1995
IL TEST COMPLEMENT 3
K920007 · Instrumentation Laboratory CO · Jun 1992